Sven Enerbäck

Title: Sven Enerbäck: Innovator in Stem Cell Technology

Introduction

Sven Enerbäck is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of stem cell research, particularly in the efficient transfer and propagation of human blastocyst-derived stem cells.

Latest Patents

Sven Enerbäck holds a patent for a method that facilitates the efficient transfer of human blastocyst-derived stem cells (hBS cells) from a feeder-supported to a feeder-free culture system. This innovative method allows for the long-term propagation of hBS cells under feeder-free conditions. The patent outlines a process that includes transferring the cells through mechanical treatment, culturing them in a suitable growth medium, and passaging the cell line every 3-10 days using enzymatic and/or mechanical treatment. The invention has significant implications for applications in myocardial regeneration and various screening and toxicity tests.

Career Highlights

Sven Enerbäck is associated with Cellartis AB, a company that focuses on stem cell technology and its applications in regenerative medicine. His work has positioned him as a key figure in advancing stem cell research and its practical applications.

Collaborations

Sven has collaborated with notable colleagues such as Peter Eriksson and Eva Karin Kilmare, contributing to the advancement of stem cell technologies and their applications in medicine.

Conclusion

Sven Enerbäck's innovative work in stem cell technology exemplifies the potential of scientific research to impact medical applications significantly. His contributions continue to pave the way for advancements in regenerative medicine.